US 12,370,079 B2Granted

Apparatus and method for thermal blockade of nerves

AssigneesThermaquil, Inc., University of Pittsburgh—Of the Commonwealth System of Higher Education

InventorsStephen R. Popielarski, Changfeng Tai, Grant M. Chapman

Life of this patent

Estimating the term…

Loading patent…

Abstract

Embodiments disclosed include systems, methods, and apparatuses, directed to administering thermal neural modulation to mammalian tissue to control nerve conduction. Embodiments disclosed include an apparatus comprising a thermal energy source, a first heat exchanger coupled to the thermal energy source and configured to receive thermal energy therefrom, a thermal applicator configured to be disposed and secured to the anatomy of a subject having a nerve therein, in contact with the skin on the anatomy and overlying a treatment portion of the nerve, the thermal applicator configured to transfer thermal energy to the skin to raise the temperature of the treatment portion of the nerve above a physiologic temperature, a second heat exchanger is coupled to the thermal applicator and configured to transfer thermal energy thereto, and a fluid conduit having a first portion coupled to the first heat exchanger and a second portion coupled to the second heat exchanger. The fluid conduit is configured to have fluid circulated therethrough to convey thermal energy from the thermal energy source via the first heat exchanger and to the thermal applicator via the second energy at a temperature.

Claims13

Dependent claims

A method comprising:

delivering thermal energy to a treatment portion of a target nerve in a body of a subject mammal via a thermal applicator disposed in operative relationship with the treatment portion to increase a temperature of the treatment portion to a first temperature above a physiologic temperature of the target nerve, the target nerve being a C-fiber nerve and/or an A-δ fiber nerve, carrying pain signals;
continuing to deliver thermal energy to the treatment portion via the thermal applicator to maintain the temperature of the treatment portion at the first temperature for a first duration sufficient to pre-condition the target nerve;
ceasing delivery of thermal energy to the treatment portion;
the continuing to deliver thermal energy and the ceasing delivery of thermal energy being such that after the ceasing delivery a withdrawal of thermal energy to a second temperature can achieve a blockade of the target nerve, the second temperature being below the physiologic temperature of the target nerve by a first degree, the second temperature being higher than a third temperature that is below the physiologic temperature of the target nerve by a second degree greater than the first degree and required to be achieved, via withdrawal of thermal energy, for a blockade of the target nerve in an absence of the pre-condition,
the first temperature being sufficient to pre-condition the target nerve or initiate a reversible, partial blockade of the target nerve, and insufficient to pre-condition or initiate a reversible, partial blockade of an A-β fiber, that is myelinated and carrying motor signals and having a portion in proximity to the treatment portion of the target nerve;
withdrawing thermal energy from the treatment portion via the thermal applicator to decrease a temperature of the treatment portion to the second temperature below the physiologic temperature of the target nerve;
and
continuing to withdraw thermal energy from the treatment portion via the thermal applicator to maintain the temperature of the treatment portion at the second temperature for a second duration sufficient to achieve a reversible blockade of the target nerve, before the target nerve has recovered from the pre-condition or reversible partial blockade, without inducing a blockade of the A-β fiber that is myelinated and carrying motor signals and having the portion in proximity to the treatment portion of the target nerve.

5 more elements

An apparatus comprising:

a thermal energy source;
a thermal energy sink;
a thermal energy conduit coupled to the thermal energy source and to the thermal energy sink;
a thermal applicator coupled to the thermal energy conduit and configured:
to be applied topically to a skin overlying a treatment portion of a target nerve in a treatment location on a body of a subject mammal, the target nerve being a C-fiber nerve and/or an A-δ fiber nerve, carrying pain and/or other undesired sensory signals,
to receive thermal energy from the thermal energy source via the thermal energy conduit and to deliver the thermal energy to the treatment portion of the target nerve, and
to receive thermal energy from the treatment portion of the target nerve and convey it to the thermal energy sink via the thermal energy conduit;
and
a controller operatively coupled to the energy source and the thermal energy sink, and configured:
to cause the energy source to provide energy to the thermal applicator via the energy conduit at a temperature and thermal energy delivery rate sufficient to raise the temperature of the treatment portion of the target nerve to a first temperature above a physiologic temperature and to maintain the first temperature for a first duration sufficient to pre-condition the target nerve,
to cease delivery of thermal energy, and
then to cause the thermal energy sink to cause thermal energy to be removed from the thermal applicator at a rate sufficient to lower the temperature of the treatment portion of the target nerve to a second temperature, below the physiologic temperature, sufficient to achieve a reversible blockade of the target nerve, the second temperature being below the physiologic temperature by a first degree, the second temperature being higher than a third temperature that is below the physiologic temperature of the target nerve by a second degree greater than the first degree and required to be achieved, via withdrawal of thermal energy, for a blockade of the target nerve in an absence of the pre-condition.

9 more elements

Dependencies are inferred from the claim text.

Facts

Application: 17/127,431Filed 18 Dec 2020 · continuation
Priority: 19 Jun 2018
Published: US 2021/0236328 A15 Aug 2021
Granted: 29 Jul 2025
Term ends: Not estimatedThe source records don’t support an estimate.

Classification28 codes

A61F 7/007
Heating or cooling appliances for medical or therapeutic treatment of the human body: characterised by electric heating
A61F 7/0085
Heating or cooling appliances for medical or therapeutic treatment of the human body: devices for generating hot or cold treatment fluids
A61F 7/10
Heating or cooling appliances for medical or therapeutic treatment of the human body: cooling bags, e.g. ice-bags
A61F 7/12
Heating or cooling appliances for medical or therapeutic treatment of the human body: devices for heating or cooling internal body cavities

Family

Application62/686,712Us provisional application · filed 19 Jun 2018
PCT/US2019/038065Parent of this continuation · filed 19 Jun 2019
Application62/949,969Us provisional application · filed 18 Dec 2019
PCT/US2020/065636Parent of this continuation · filed 17 Dec 2020
US 2021/0236328 A1Pre-grant publication · published 5 Aug 2021
US 12,370,079 B2This patent

From the US filing history. Foreign family members aren’t listed.